Need for differential discounting of costs and health effects in cost effectiveness analyses

被引：159

作者：

Brouwer, WBF

Niessen, LW

Postma, MJ

Rutten, FFH

机构：

[1] Erasmus MC, Inst Med Technol Assessment, NL-3000 DR Rotterdam, Netherlands

[2] Univ Groningen, Inst Drug Explorat, Groningen, Netherlands

来源：

BRITISH MEDICAL JOURNAL | 2005年 / 331卷 / 7514期

关键词：

D O I：

10.1136/bmj.331.7514.446

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：446 / 448

页数：3

共 22 条

[1]

BROUWER WBF, 2000, J HEALTH SERV RES PO, V5, P1

[2]

BROUWER WBF, 2005, LEVEL DISCOUNT RATES

[3]

CAIRNS JA, 2001, EC EVALUATION HLTH C

[4]

Drummond M., 2015, METHODS EC EVALUATIO, V4

[5] Guidelines for authors and peer reviewers of economic submissions to the BMJ [J].

Drummond, MF ;

Jefferson, TO .

BRITISH MEDICAL JOURNAL, 1996, 313 (7052) :275-283

[6]

Gold MR, 1996, COST EFFECTIVENESS H

[7] Discounting for health effects in cost-benefit and cost-effectiveness analysis [J].

Gravelle, H ;

Smith, D .

HEALTH ECONOMICS, 2001, 10 (07) :587-599

[8] Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63) [J].

Gray, A ;

Clarke, P ;

Farmer, A ;

Holman, R .

BRITISH MEDICAL JOURNAL, 2002, 325 (7369) :860-863

[9]

*HER MAJ TREAS, 2004, GREEN BOOK

[10]

KEELER EB, 1983, MANAGE SCI, V29, P300, DOI 10.1287/mnsc.29.3.300

← 1 2 3 →